Publication | Closed Access

Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination

Nucleolin OverexpressionBreast OncologyIntracellular DeliveryDrug TargetingPolymer-drug ConjugateMedicineBreast CancerTumor TargetingCancer TreatmentSynergistic Drug CombinationPharmacologyCell BiologyTumor MicroenvironmentTumor Biology